Juvenile myoclonic epilepsy (JME) is an idiopathic, age-related generalized epileptic syndrome, featuring generalized tonic-clonic and absence seizures as well as myoclonic jerks. Except for some case reports, little is known about type and frequency of nonconvulsive status epilepticus (NCSE) in adult patients with JME. In a retrospective study we therefore reviewed all patients with JME, who had been referred to our hospital between 1994 and 1999 for the occurrence of NCSE. Of the 69 patients with JME seen within these 6 years three women had typical absence status-one of them two times-and one woman had impulsive-petit-mal status. All four patients had a history of myoclonic, absence and generalized tonic-clonic seizures. Because of the extreme rarity of impulsive-petit-mal status the corresponding case history is presented in detail. According to our findings the prevalence of NCSE in JME can be estimated at 5.8%, the incidence at 1.2% per year with a clear preponderance of female gender.
INTRODUCTION
Juvenile myoclonic epilepsy (JME) is an idiopathic, age-related generalized epileptic syndrome, that features generalized tonic-clonic as well as absence seizures and myoclonic jerks. Seizures are normally provoked by sleep deprivation, alcohol and flickering light. The prevalence of this syndrome is higher than usually appreciated and should account for about 5-10% of all types of epilepsy [1] [2] [3] . The characteristic EEG pattern consists of generalized, symmetric spike-and polyspike-slow wave discharges frequently accompanied by myoclonic jerks 4, 5 . The usual treatment options are either valproic acid 6 or lamotrigine 7 .
Up to now little has been known about the type and frequency of nonconvulsive status epilepticus (NCSE) in patients with JME, this topic has been addressed in only few case reports. In a retrospective study we therefore systematically reviewed all patients with JME, who were referred to our hospital between 1994 and 1999, for the occurrence of NCSE.
PATIENTS AND METHODS
The Department of Neurology of the University Clinic Münster provides a neurological service to 500 000 inhabitants aged >16 years in the area around Münster. JME was diagnosed, when patients had myoclonic jerks (MJ), especially upon awakening and generalized polyspike-waves (PSW) in EEG. Additionally absence seizures (AS) and generalized tonic-clonic seizures could be present but were not mandatory for diagnosis. All patients with JME, who were treated between 1994 and 1999 in our epilepsy devision, were included in this study. All patients had been investigated by thorough history taking and by neurological examination. EEG recordings were performed on a 24-channel EEG machine with 21 electrodes placed according to the 10-20 system. Diagnosis was made in accordance with the proposal of the International League Against Epilepsy 8, 9 . In brief, NCSE was defined as state of impaired consciousness without convulsions lasting at least 60 minutes. In more detail, the different status forms observed in this study were defined as follows: Typical absence status (TAS) appears clinically either as stupor or as a fluctuating confusional state. Mild infrequent myoclonic jerks or automatisms can be present, the ictal EEG features generalized continous or discontinous spike-wave discharge 10 . It is worth mentioning that complex partial seizures can sometimes be hardly distinguishable from TAS. Ictal EEG shows continuous or intermittent focal or generalized spikes or sharp and slow waves. Myoclonic status (MS) is characterized by uncoordinated jactations of variable frequency and intensity with slight impairment of consciousness. The characteristic ictal EEG pattern shows intermittent spike-wave and polyspike-wave discharges 11 .
RESULTS
Between 1994 and 1999 69 patients (46 women, mean age 29.4 ± 10.2 and 23 men, mean age 30.9 ± 11.3) with JME were examined and treated at our hospital. Age at disease-onset was 16.6 ± 5.4 years for the whole cohort without significant difference between the sexes (women 16.4 ± 6.0, men 16.9 ± 4.0).
Seizure types were myoclonic in 100%, absences in 43% and generalized tonic-clonic in 90% (Fig. 1) .
Actual treatment consisted of valproic acid (VPA) monotherapy in 27 (39.0%), lamotrigine (LTG) monotherapy in 15 (21.7%), ethosuximide monotherapy in three (4.3%), carbamazepine (CBZ) monotherapy in three (4.3%), a combination therapy of VPA and LTG in seven (10.1%), of LTG and CBZ in 6 (8.7%) and of VPA and CBZ in three (4.3%) patients. Five (7.2%) patients refused medication. Remarkably 24 (34.8%) patients had been treated with carbamazepine or phenytoin and two (2.8%) with phenobarbital for some time.
In three female patients (4.3%) aged 28, 34, and 51 TAS was diagnosed and treated successfully with clonazepam, one of them twice during the study period. In all these patients a typical history of myoclonic jerks and absence seizures as well as generalized tonic-clonic seizures was revealed later. Two patients had experienced TAS before. At the time of TAS, treatment comprised of CBZ monotherapy in three instances. In one instance therapy with an unknown anticonvulsant had just been discontinued by the patient herself.
One female patient, aged 69, presented with myoclonic status (MS). She also had a history of myoclonic jerks, absence seizures and generalized tonic-clonic seizures. No other status forms were observed and no male JME patient was affected. Therefore the prevalence of nonconvulsive status epilepticus in this study amounts to 5.7%, the corresponding incidence totals 1.2% per year. For the TASsubgroup the prevalence was 4.3% (incidence 0.87% per year) and for MS-subgroup 1.4% (incidence 0.28% per year) respectively. Since NCSE occured only in patients with myoclonic jerks, absence seizures and generalized tonic-clonic seizures the prevalence for this subgroup was figured at 10.8% and the corresponding incidence at 2.2% per year. 
Case report
Because of the extreme rarity of MS we wish to present the last case in greater detail. This 69 year old retired lawyer had a history of epilepsy since she had been a teenager. In the last two years she was treated in our hospital several times after having suffered generalized tonic-clonic seizures in conjunction with alcohol intake. In her adolescence she had experienced quite frequently myoclonic jerks of arms and legs shortly after awakening and periods of minutes during which she seemed to be sleepy and lethargic. Since her mid-thirties she had infrequently experienced GTCS. An ictal EEG had never been registered. Recent interictal EEGs had constantly been abnormal with mild general slowing but no focus or sharp-slow wave discharges. Analysis of cerebrospinal fluid was normal. MRimages of the head showed a leukoencephalopathy, leading to the diagnosis of symptomatic epilepsy with secondary GTCS. For several decades she had been treated with phenytoin, (PHT) without, however, taking medication regularly as blood-level monitoring revealed. Beside the epilepsy she had suffered from arterial hypertension for many years. At the occasion we want to report on, the patient was admitted to our hospital, because she had been in a sleepy state for a few hours, being inconstantly able to answer simple questions, e.g. giving her name. Her thinking was severely slowed and her memory was disturbed. A few times a minute she performed symmetrical jerks with her arms and backward twitches with her trunk and head. Neurological examination revealed no other pathological finding. An EEG showed generalized polyspike and slow wave discharges and myocloclonic jerks (Fig. 2) .
We therefore diagnosed MS and, despite the pathological MRI, we finally proposed JME as the underlying condition. After fractionated administration of 2 mg clonazepam the myoclonic jerks stopped and the patient's vigilance and EEG immediately returned to her praemorbid state. She had amnesia for the time of the status. As at earlier occasions she remained uncooperative. Again she refused to change her antiepileptic medication and left our clinic the next morning.
DISCUSSION
This retrospective study attempts to close a gap in the existing literature on JME. Whereas much is known about its incidence, its clinical and EEG features and, last, but not least, about therapy options, the question of types and frequencies of NCSE in JME had not often been investigated before systematically. This topic has largely been addressed in case reports. Some JME patients, who suffered NCSE, can be found in clinical series, which were collected with different aims.
Other authors report on NCSE without giving the exact diagnosis of the underlying epileptic syndrome 23, 24 .
In this retrospective study three women out of 69 patients with JME suffered TAS, one of them twice, whereas only one woman experienced MS. Other status types were not observed. The prevalence of NCSE in patients with JME therefore reaches 5.8%, the incidence 1.2% per year in this sample. The prevalence of TAS amounts to 4.3% (incidence 0.96% per year). This corresponds well to the results of Agathonikou et al. 21 (Table 1) , who diagnosed this status type in two of 30 JME patients (6.7%), when analysing the frequency of TAS in adults. This was much lower than, in the same study, patients with phantom absences and generalized tonic-clonic seizures (46.2%), perioral myoclonia with absences (57.1%) and eyelid myoclonia with absences (18.2%). As in our study, the JME patients affected by TAS all had a history of myoclonic jerks, absence seizures and generalized tonic-clonic seizures. This gives reason to speculate that this particular syndrome predisposes for TAS in patients with JME.
The prevalence of MS in our study was 1.4%. This is in accordance with Christian's suggestion 13 , that MS occurs only very rarely. Remarkably, in a series of 85 JME patients, 21% of them had MS 16 . However, in 17 patients this diagnosis was based on the patient's report alone, only one case (1.2%) was witnessed by the authors and documented by EEG.
Tomson et al. 19 , in their retrospective study used an opposite approach and analysed the frequency of different epileptic syndromes in a large series of NCSE in adults. Whereas five of 32 patients had a history of absence epilepsy only one had JME, thus suggesting again, that NCSE in patients with JME is a rare event.
Whereas complex partial status, which often resembles TAS clinically, is usually difficult to treat, TAS and MS seem to respond well to administration of benzodiaszepines such as diazepam or preferentially clonazepam 19 . Our study gave further evidence of this fact, as all four patients promptly recovered from the status after administration of 1 to 2 mg clonazepam. Apart from that, intravenous administration of VPA may be another therapeutic option 18 . All of our patients with NCSE were taking inadequate medication at the time of presentation (CBZ, PHT or none). This corresponds to the results of Genton et al. 17 . They found worsening of epilepsy in patients with JME, who were treated with CBZ or PHT. Besides an increase of MJ two of their patients suffered MS and one a mixed absence and myoclonic status.
Despite its rare occurrence in patients with JME, MS may be seen more often in patients with brain lesions of different origin 25 . In this instance the treatment is usually difficult and the prognosis is poor 26 .
Because of these fundamental differences between symptomatic MS and MS in patients with idiopathic generalised epilepsy we finally would like to propose a modification of the international nomenclature. The myoclonic seizures in JME were described by Janz and Christian in 1957 as 'impulsive petit mal'. Therefore it would make sense to address myoclonic status in these patients as 'impulsive petit mal status'. This term, rather than myoclonic status, was used before the current classification was published in 1981 and could be restored in future classifications.
